Hims & Hers to offer at-home blood draws and lab testing with new acquisition
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
Hosted on MSN13h
Hims & Hers to introduce at-home lab testing with Trybe Labs acquisition
Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...
Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition
Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...
HIMS Stock Rockets on At-Home Blood Test Plans
Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce ...
Yahoo Finance23d
Medical Blood Lancet Market to Reach USD 1,552.9 Million by 2024, USD 3,682.8 Million by 2033, Growing at Over 10.1% CAGR : Dimension Market Research
The Global Medical Blood Lancet Market is projected to reach USD 1,552.9 million by the end of 2024 and grow steadily towards an expected value of USD 3,682.8 million by 2033 with compound annual ...
Hims & Hers is getting into the at-home blood testing business
After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...
Why Hims & Hers Health (HIMS) Is Rallying Today
By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more ...
Business Wire10d
Tasso Announces Next Generation Technology for Patient-Centric Dried Blood Spot Sample Collection
Tile-T20 is the first DBS collection cartridge designed specifically for use with patient-centric blood lancets. Tile-T20 collects four precise, volumetrically-controlled blood samples that meet ...